Krystal Biotech Inc

Stock Chart, Company Information, and Scan Results

$286.95(as of May 4, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Krystal Biotech Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$286.95
Ticker SymbolKRYS
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees295
CountyUSA
Market Cap$7,831.1M
EBIDTA162.9M
10-Day Moving Average270.64
P/E Ratio41.96
20-Day Moving Average268.63
Forward P/E Ratio46.08
50-Day Moving Average262.33
Earnings per Share6.84
200-Day Moving Average218.42
Profit Margin47.99%
RSI64.11
Shares Outstanding29.4M
ATR11.52
52-Week High298.30
Volume651,427
52-Week Low122.80
Most Recent Support Level257.53
Book Value1,219.6M
Most Recent Resistance Level281.65
P/B Ratio7.05
Upper Keltner294.56
P/S Ratio22.09
Lower Keltner242.71
Debt-to-Equity Ratio294.56
Next Earnings Date05/11/2026
Cash Surplus393.4M
Next Ex-Dividend DateUnknown

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Krystal Biotech Inc In Our Stock Scanner

As of May 05, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.